CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Deferred Compensation	Retained Earnings (Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)		14,762					(51)
Beginning balance at Feb. 01, 2020	$ 235,187	$ 1,476	$ 139,041	$ 2,956	$ 108,215	$ (13,545)	$ (2,956)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock awards (in shares)		171
Vesting of stock awards	0	$ 17	(17)
Stock-based compensation	7,388		7,388
Purchase and retirement of shares (in shares)		(292)
Purchase and retirement of shares	(15,452)	$ (29)	(4,799)		(10,624)
Change in cumulative translation adjustment	(876)					(876)
Change in fair value of cash flow hedges, net of income taxes	(749)					(749)
Deferral of common stock into deferred compensation plan	0			139			$ (139)
Deferral of common stock into deferred compensation plan (in shares)							(4)
Net income (loss)	(148,129)				(148,129)
Ending balance (in shares) at Oct. 31, 2020		14,641					(55)
Ending balance at Oct. 31, 2020	77,369	$ 1,464	141,613	3,095	(50,538)	(15,170)	$ (3,095)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)		14,637					(52)
Beginning balance at Aug. 01, 2020	61,515	$ 1,464	138,350	3,025	(63,862)	(14,437)	$ (3,025)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock awards (in shares)		4
Vesting of stock awards	0	$ 0
Stock-based compensation	3,275		3,275
Purchase and retirement of shares	(8)		(12)		4
Change in cumulative translation adjustment	216					216
Change in fair value of cash flow hedges, net of income taxes	(949)					(949)
Deferral of common stock into deferred compensation plan	0			70			$ (70)
Deferral of common stock into deferred compensation plan (in shares)							(3)
Net income (loss)	13,320				13,320
Ending balance (in shares) at Oct. 31, 2020		14,641					(55)
Ending balance at Oct. 31, 2020	77,369	$ 1,464	141,613	3,095	(50,538)	(15,170)	$ (3,095)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)		14,641					(55)
Beginning balance (in shares)		14,641					(57)
Beginning balance at Jan. 30, 2021	93,377	$ 1,464	148,519	3,165	(42,790)	(13,816)	$ (3,165)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock awards (in shares)		345
Vesting of stock awards	0	$ 35	(35)
Stock-based compensation	25,036		25,036
Purchase and retirement of shares (in shares)		(518)
Purchase and retirement of shares	(45,187)	$ (52)	(9,510)		(35,625)
Change in cumulative translation adjustment	854					854
Deferral of common stock into deferred compensation plan	0			208			$ (208)
Deferral of common stock into deferred compensation plan (in shares)							(3)
Net income (loss)	148,168				148,168
Ending balance (in shares) at Oct. 30, 2021		14,468					(60)
Ending balance at Oct. 30, 2021	222,248	$ 1,447	164,010	3,373	69,753	(12,962)	$ (3,373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)		14,831					(59)
Beginning balance at Jul. 31, 2021	168,185	$ 1,483	164,290	3,304	15,697	(13,285)	$ (3,304)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock awards (in shares)		9
Vesting of stock awards	0	$ 1	(1)
Stock-based compensation	6,594		6,594
Purchase and retirement of shares (in shares)		(372)
Purchase and retirement of shares	(31,722)	$ (37)	(6,873)		(24,812)
Change in cumulative translation adjustment	323					323
Deferral of common stock into deferred compensation plan	0			69			$ (69)
Deferral of common stock into deferred compensation plan (in shares)							(1)
Net income (loss)	78,868				78,868
Ending balance (in shares) at Oct. 30, 2021		14,468					(60)
Ending balance at Oct. 30, 2021	$ 222,248	$ 1,447	$ 164,010	$ 3,373	$ 69,753	$ (12,962)	$ (3,373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)		14,468					(60)